PEDIATRICS Vol. 87 No. 3 March 1991, pp. 339-351
This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Litov, R. E.
Right arrow Articles by Combs, G. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Litov, R. E.
Right arrow Articles by Combs, G. F., Jr
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Selenium in Pediatric Nutrition

Richard E. Litov PhD1 and Gerald F. Combs Jr PhD2

1 From the Mead Johnson Research Center, Bristol-Myers Squibb Company, Evansville, Indiana
2 From the Division of Nutritional Sciences, Cornell University, Ithaca, New York

Se is an essential nutrient that provides antioxidant protection in concert with vitamin E. Several selenoproteins have been identified, but only one, SeGSHpx, has a known function, that of neutralizing toxic hydroperoxides. Plasma Se concentration, being responsive to changes in Se intake, is the most practical and widely used measure of nutritional Se status. The plasma Se concentrations of the majority of healthy infants and children fall within the range of 50 to 150 µg/L. Although SeGSHpx activity measures the metabolically functional form of Se, the lack of a standardized analytical method has limited its usefulness as an index of nutritional Se status. Se deficiency was first observed in animals, but it is now recognized to occur in humans. Two human diseases associated with severe nutritional Se deficiency have been reported from China: a juvenile cardiomyopathy named Keshan disease and a chondrodystrophy named Kaschin-Beck disease. Long-term TPN, which provides negligible amounts of intrinsic Se, has been demonstrated in some cases to result in biochemical and clinical impairment. Although there are no consistent signs and symptoms characteristic of TPN-associated Se deficiency, in addition to the low blood selenium levels, some patients will experience leg muscle pain and altered serum transaminase and creatine kinase activities. These manifestations of Se deficiency usually take years to develop.

Recent information about the amount of dietary Se needed to maximize plasma SeGSHpx activity in adult men has allowed for better estimates of the Se requirement for humans. Recommended daily dietary allowances published recently by the National Academy of Sciences have been revised for infants and children in this paper by making appropriate adjustments for the protein requirements of these age-groups. These recommended intakes for Se can generally be met by consuming adequate amounts of cereals, meat, eggs, dairy products, human milk, and infant formula, which are good sources of highly available Se and are of low risk of providing excess amounts of Se. Suboptimal Se intakes by pregnant women may predispose their infants to low Se status at birth, which in turn may affect the infants' ability to maintain adequate Se status during the first few months of life. In those situations where protein intake is restricted, such as in phenylketonuria and maple syrup urine disease, Se-supplemented formulas should be used. The most critical situation for Se supplementation is in pediatric patients receiving long-term TPN therapy. When supplementing with Se, consideration must be given to the amount and form of Se to be used; with long-term TPN therapy, plasma Se levels should be monitored.

Submitted on March 9, 1990
Accepted on July 2, 1990


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
JPEN J Parenter Enteral NutrHome page
E. de Berranger, S. Colinet, L. Michaud, R. Cremer, C. Fourrier, G. M. Breviere, D. Turck, and F. Gottrand
Severe Selenium Deficiency Secondary to Chylous Loss
JPEN J Parenter Enteral Nutr, March 1, 2006; 30(2): 173 - 174.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
S. K. McLachlan, C. D. Thomson, E. L. Ferguson, and J. E. McKenzie
Dietary and Biochemical Selenium Status of Urban 6- to 24-Month-Old South Island New Zealand Children and their Postpartum Mothers
J. Nutr., December 1, 2004; 134(12): 3290 - 3295.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child. Fetal Neonatal Ed.Home page
G. Bogye, G. Alfthan, T. Machay, and L. Zubovics
Enteral yeast-selenium supplementation in preterm infants
Arch. Dis. Child. Fetal Neonatal Ed., May 1, 1998; 78(3): 225F - 226.
[Abstract] [Full Text]


Home page
Food Science and Technology InternationalHome page
J. Ortuno, G. Ros, M.J. Periago, C. Martinez, and G. Lopez
Biodisponibilidad del selenio y metodos de evaluacion/Selenium bioavailability and methods of evaluation
Food Science and Technology International, January 1, 1996; 2(3): 135 - 150.
[PDF]